Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Swissmedic OKs Pfizer/BioNTech COVID-19 Booster Jabs For High Risk People

10/26/2021 | 11:33pm EST


ę MT Newswires 2021
All news about MODERNA, INC.
05:29pU.S. administers 464.4 mln doses of COVID-19 vaccines - CDC
RE
05:18pU.S. CDC Says Delivered 578,263,565 Doses Of COVID-19 Vaccine As Of Dec 2
RE
04:39pUS Stocks Rebound Following Recent Sell-Offs as Omicron Variant Concerns Subside
MT
01:36pStocks Led Higher Midday by Financials, Energy; GlaxoSmithKline Says Sotrovimab Showed ..
MT
12:29pWhat COVID-19 vaccine and drug makers have to say about Omicron
RE
11:21aCOVID-19 vaccines less effective in cancer patients receiving chemotherapy
AQ
05:32aModerna Agrees to Supply the UK With Additional 60 Million COVID-19 Vaccine Doses
MT
05:10aHARVARD UNIVERSITY : Moderna edges out Pfizer vaccine in head-to-head comparison; Large-sc..
AQ
12:26aModerna To Ready Omicron Booster Shot For US FDA Approval By March 2022
MT
12/01UK Secures 114 Million Additional COVID-19 Shots From Pfizer/BioNTech, Moderna
MT
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 449 M - -
Net income 2021 11 169 M - -
Net cash 2021 12 344 M - -
P/E ratio 2021 11,5x
Yield 2021 -
Capitalization 126 B 126 B -
EV / Sales 2021 6,51x
EV / Sales 2022 5,00x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 301,49 $
Average target price 272,53 $
Spread / Average Target -9,60%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.197.32%125 937
LONZA GROUP AG28.34%58 955
IQVIA HOLDINGS INC.44.70%49 527
SEAGEN INC.-9.64%28 937
CELLTRION, INC.-40.67%24 625
ICON PUBLIC LIMITED COMPANY40.00%22 219